Savior Lifetec Corporation

Savior Lifetec (SLC) specializes in
manufacturing API and finished dosage form, especially carbapenem antibiotics,
including imipenem/cilastatin, meropenem, and ertapenem. Our facilities for API
production have been approved by USFDA, MHRA(UK), Afssaps (Fr), PMDA (Japan), KFDA (Korea),
and TFDA (Taiwan).
Both DMFs and EDMFs are available. We also offer FDF of carbapenem from our dedicated
injectable plant which is approved by TFDA and EU authority and is expected to
be inspected by USFDA in 2013.

We currently work on the development of
peptide drugs: eg. Leuprolide, from API to slow-release injectable. In
addition, we are seeking collaboration with our potential customers in the toll
manufacture of injectable products relating to the areas of oncology and liquid
injectables for the regulated markets as well as emerging markets.